Retatrutide Telehealth Prescriptions
Telehealth has revolutionized access to weight loss medications, eliminating geographic barriers and reducing costs. Here is how telehealth prescribing works and how it positions you for retatrutide access.
The telehealth revolution has made weight loss medications accessible to millions who could not previously obtain them -- patients in rural areas without obesity medicine specialists, patients who cannot take time off work for monthly clinic visits, and patients priced out of brand-name medications. As retatrutide moves toward availability (Jastreboff et al., NEJM 2023), telehealth providers will be at the forefront of patient access, just as they have been for semaglutide and tirzepatide.
Current Availability
Retatrutide is not yet FDA-approved. Telehealth access to retatrutide specifically is limited. Currently available through telehealth: compounded semaglutide and tirzepatide with full medical oversight.
How Telehealth Weight Loss Treatment Works
The process is straightforward and typically takes less than a week from initial consultation to receiving medication at your door. You complete an online medical questionnaire covering your health history, current medications, weight loss goals, and any contraindications. A licensed provider reviews your information and conducts a consultation (video or asynchronous depending on the platform). If appropriate, the provider prescribes medication and sends it to a partnered compounding pharmacy. The pharmacy compounds and ships the medication directly to your home with injection supplies and instructions.
What Makes a Good Telehealth Provider
- Licensed providers: Board-certified physicians, NPs, or PAs with weight management experience
- Ongoing monitoring: Regular check-ins, dose titration guidance, and lab monitoring
- Transparent pricing: No hidden fees, membership charges, or surprise costs
- Vetted pharmacy partners: Licensed compounding pharmacies with quality standards
- Responsive support: Access to medical team for questions and side effect management
- Evidence-based protocols: Treatment based on clinical guidelines, not marketing
Available Now Through Telehealth
While retatrutide access expands, highly effective weight loss medications are available through telehealth today. TRIMI offers compounded semaglutide from $99/mo and compounded tirzepatide from $125/mo. These medications produce significant weight loss (15-22%) with the convenience and affordability of telehealth-based care. Establishing a telehealth relationship now means seamless access to new medications like retatrutide as they become available.
Visit our treatments page to explore your options.
Medical Disclaimer
This article is for educational purposes only. Retatrutide is not FDA-approved. Telehealth prescribing regulations vary by state. Consult with a licensed healthcare provider for treatment decisions.
Start Treatment From Home
Telehealth weight loss treatment. Semaglutide from $99/mo, tirzepatide from $125/mo.
Get Started TodayMore on Retatrutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).